INGN Inogen Inc

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 08, 2022

 

 

INOGEN, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware			001-36309	33-0989359
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
301 Coromar Drive
Goleta, California				93117
(Address of Principal Executive Offices)				(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (805) 562-0500

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value		INGN		The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

---

Item 5.07 Submission of Matters to a Vote of Security Holders.

Inogen, Inc. (the “Company”) held its 2022 annual meeting of stockholders on June 8, 2022 (the “Annual Meeting”). Of the 22,835,794 shares of the Company’s common stock outstanding as of the record date of April 11, 2022, 20,595,021 shares were represented at the Annual Meeting, either by proxy or by attending the meeting, constituting approximately 90.18% of the outstanding shares of common stock. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:

1.

Election of Class II Directors. The following nominees were elected to serve as Class II directors, to hold office until the Company’s 2025 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified:

 

Nominee		Votes For		Votes Withheld		Broker Non-Votes
Kevin King		19,195,244		114,388		1,285,389
Mary Kay Ladone		19,195,296		114,336		1,285,389
Nabil Shabshab		14,647,832		4,661,800		1,285,389

2.

Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 was ratified based on the following results of voting:

 

Votes For		Votes Against		Abstentions		Broker Non-Votes
20,562,878		8,721		23,422		—

3.

Advisory Vote on Executive Compensation. The Company’s stockholders advised that they were in favor of the named executive officers’ compensation as disclosed in the proxy statement. The votes regarding the proposal were as follows:

 

Votes For		Votes Against		Abstentions		Broker Non-Votes
18,392,222		885,879		31,531		1,285,389

 

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			INOGEN, INC.
Date:	June 13, 2022	By:	/s/ Kristin Caltrider
			Kristin Caltrider Executive Vice President Chief Financial Officer Treasurer (Principal Accounting and Financial Officer)

 

---